Evidence map›Paper›PMID 26922382›Full record

ArticleJournal of autoimmunity2016

Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis.

Jameson T Crowley, Klemen Strle, Elise E Drouin, Annalisa Pianta, Sheila L Arvikar, Qi Wang, Catherine E Costello, Allen C Steere

Open access · greenAbstract read
In one paragraph

Article in Journal of autoimmunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Anti-RA33 Antibodies Are Present in Patients With Lyme Disease.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2025
    Observational
  5. Review
  6. Article
  7. Article
  8. Lyme Arthritis: A 50-Year Journey.The Journal of infectious diseases · 2024
    Article
  9. Article
  10. Synthesis of aMolecules (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Lyme Arthritis.Infectious disease clinics of North America · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jameson T CrowleyCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. Electronic address: jcrowley6@mgh.harvard.edu.
Klemen StrleCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Elise E DrouinCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Annalisa PiantaCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Sheila L ArvikarCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Qi WangCenter for Biomedical Mass Spectrometry, Boston University School of Medicine, Boston, MA, United States.
Catherine E CostelloCenter for Biomedical Mass Spectrometry, Boston University School of Medicine, Boston, MA, United States.
Allen C SteereCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Harvard University · USBoston University · US

Funding

Mass Spectrometry Resource for Biology and MedicineP41GM104603 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2012 to 2017
$10.4M
Borrelia burgdorferi-Induced Autoimmunity in Lyme DiseaseR01AI101175 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI STEERE, ALLEN C · 2013 to 2021
$3.6M
MALDI-TOF/TOF MS TO SUPPORT BIOMEDICAL RESEARCHS10OD010724 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2012 to 2012
$590k
Defining Microbial and Host Factors in Innate Immune Responses in Lyme ArthritisK01AR062098 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI STRLE, KLEMEN · 2012 to 2014
$398k
NHLBI NIH HHS HHSN268201000031CNIAID NIH HHS R01 AI101175NIAID NIH HHS R01 AI-110175NIAMS NIH HHS K01 AR062098NIAMS NIH HHS K01-AR062098NIGMS NIH HHS P41 GM104603NIH HHS S10 OD010724PHS HHS HHSN268201000031C
6 · The paper itself

Abstract

Infection-induced autoimmunity is thought to be a contributing factor in antibiotic-refractory Lyme arthritis, but studies of autoimmunity have been hindered by difficulty in identifying relevant autoantigens. We developed a novel approach that begins with the identification of T cell epitopes in synovial tissue using tandem mass spectrometry. Herein, we identified an immunogenic HLA-DR-presented peptide (T cell epitope) derived from the source protein matrix metalloproteinase-10 (MMP-10) from the synovium of a patient with antibiotic-refractory arthritis. This finding provided a bridge for the identification of autoantibody responses to MMP-10, the "first autoimmune hit" in a subgroup of patients with erythema migrans, the initial skin lesion of the infection. Months later, after priming of the immune response to MMP-10 in early infection, a subset of patients with antibiotic-responsive or antibiotic-refractory arthritis had MMP-10 autoantibodies, but only patients with antibiotic-refractory arthritis had both T and B cell responses to the protein, providing evidence for a "second autoimmune hit". Further support for a biologically relevant autoimmune event was observed by the positive correlation of anti-MMP-10 autoantibodies with distinct synovial pathology. This experience demonstrates the power of new, discovery-based methods to identify relevant autoimmune responses in chronic inflammatory forms of arthritis.

Indexed as

Anti-Bacterial AgentsAntigen PresentationAutoantibodiesAutoantigensAutoimmunityB-LymphocytesBorrelia burgdorferiDrug ResistanceEpitopes, T-LymphocyteHLA-DR AntigensHumansImmunoglobulin GImmunoglobulin MImmunohistochemistryLyme DiseaseMatrix Metalloproteinase 10Anti-Bacterial AgentsAutoantibodiesAutoantigensEpitopes, T-LymphocyteHLA-DR AntigensImmunoglobulin GImmunoglobulin MMatrix Metalloproteinase 10Matrix Metalloproteinase 3PeptidesAutoimmunityErythema migransHLA-DR-presented peptidesLyme arthritisMMP-10

Identifiers

PMID26922382
PMCPMC4826816
OpenAlexW2286099853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.